Combined package with drug delivery device

- Janssen Pharmaceutica NV
Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description

FIG. 1 is a perspective view of a new design of a combined package with drug delivery device disposed therein;

FIG. 2 is a perspective view of the combined package with drug delivery device of FIG. 1 shown with a lid removed;

FIG. 3 is a top view of the combined package with drug delivery device of FIG. 1;

FIG. 4 is a top view of the combined package with drug delivery device of FIG. 2;

FIG. 5 is a bottom view of the combined package with drug delivery device of FIG. 1;

FIG. 6 is a left view of the combined package with drug delivery device of FIG. 1;

FIG. 7 is a right view of the combined package with drug delivery device of FIG. 1;

FIG. 8 is a front view of the combined package with drug delivery device of FIG. 1;

FIG. 9 is a back view of the combined package with drug delivery device of FIG. 1; and,

FIG. 10 is an exploded view of the combined package with drug delivery device of FIG. 1.

In the drawings, the broken lines are for the purpose of illustrating portions of the package that form no part of the claimed design.

Claims

The ornamental design for a combined package with drug delivery device, as shown and described.

Referenced Cited
U.S. Patent Documents
D430015 August 29, 2000 Himbert
6228324 May 8, 2001 Hasegawa et al.
D549094 August 21, 2007 Oner
D569721 May 27, 2008 Gedanke
D623935 September 21, 2010 Kim et al.
D697398 January 14, 2014 Guevara-ludt
D743249 November 17, 2015 Wintmolders
D750502 March 1, 2016 Kirchmayr
D754547 April 26, 2016 Psimadas
D758180 June 7, 2016 Wintmolders
9422094 August 23, 2016 Niiro
D765520 September 6, 2016 Gunder
D767985 October 4, 2016 Schouten
D774903 December 27, 2016 Joergensen
D775945 January 10, 2017 DiChiara
D780599 March 7, 2017 Tilahun
D785451 May 2, 2017 Biery
D788936 June 6, 2017 Schill et al.
D790987 July 4, 2017 Damon
D790988 July 4, 2017 Vasiliadis
D804962 December 12, 2017 Fox
D808823 January 30, 2018 Greene
D810556 February 20, 2018 Holm
D814314 April 3, 2018 Mecker
D814918 April 10, 2018 Bos
D818815 May 29, 2018 Psimadas
10053272 August 21, 2018 Doherty
D840800 February 19, 2019 Farrell
D841460 February 26, 2019 Toledo
D842092 March 5, 2019 Toledo
D847253 April 30, 2019 Chang
D847624 May 7, 2019 Farrell
D850289 June 4, 2019 McCay
D853249 July 9, 2019 McKendree
D854408 July 23, 2019 Farrell
D855450 August 6, 2019 Klein
D856793 August 20, 2019 Debnath
D860435 September 17, 2019 Wang
D870550 December 24, 2019 Klein
D871205 December 31, 2019 Farrell
D873131 January 21, 2020 Watanabe
D877613 March 10, 2020 McFaul
10577165 March 3, 2020 Sadowski et al.
D882415 April 28, 2020 Duarte de Castro
D887283 June 16, 2020 Sennett
D887700 June 23, 2020 Folger
D892636 August 11, 2020 Troudt
D898588 October 13, 2020 An
D906102 December 29, 2020 Cook
D909890 February 9, 2021 Bryzek
D915904 April 13, 2021 Duarte de Castro
D918710 May 11, 2021 Hampton
D920573 May 25, 2021 Scudieri
D934069 October 26, 2021 Cook
D938831 December 21, 2021 Picken
D939139 December 21, 2021 Waters
11230419 January 25, 2022 Tilahun
D945847 March 15, 2022 Chen
D949018 April 19, 2022 Gysel
D953886 June 7, 2022 Collier
D957245 July 12, 2022 Müller
D958645 July 26, 2022 Debnath
D959052 July 26, 2022 Gerhards
D961376 August 23, 2022 Cook
20180085515 March 29, 2018 Mide et al.
Foreign Patent Documents
113226 February 1992 AU
316236 September 2007 AU
201713235 June 2017 AU
2015001855 December 2014 CL
2017001388 January 2016 CL
2020001658 June 2020 CL
2020001659 June 2020 CL
2020001660 June 2020 CL
2020001661 June 2020 CL
09046884 September 2009 CO
000243894-0001 January 2005 EM
20200007409 June 2020 NC
D139069 February 2011 TW
D171654 November 2015 TW
Other references
  • Dispositivo de medicamento Spravato (Janssen Pharmaceutica NV) Jun. 3, 2019, https://www.scmp.com/news/world/united-states-canada/article/2188801/fda-approves-spravato-fast-acting-ketamine-nasal.
Patent History
Patent number: D985384
Type: Grant
Filed: Dec 18, 2019
Date of Patent: May 9, 2023
Assignee: Janssen Pharmaceutica NV (Beerse)
Inventors: Michael Cannamela (Atlantic Highlands, NJ), Emma Louise Hubert (San Jose, CA)
Primary Examiner: Rhea Shields
Application Number: 29/717,663
Classifications
Current U.S. Class: D9/416